Indian Enoxaparin Exporters: Complete Supplier Ranking with Market Share — 505 Manufacturers (2026) — TransData Nexus

Q: Who is the largest enoxaparin buyer importing from India?

FRESENIUS KABI USA, LLC (UNITED STATES) is the largest enoxaparin importer from India with a 23.2% market share and import value of $48.6M.

Q: How many enoxaparin buyers import from India?

There are 505 active enoxaparin buyers importing from India, with a combined import market of $209.4M across 3,309 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top enoxaparin buyers from India?

The top 5 enoxaparin buyers — FRESENIUS KABI USA, LLC, BOSTON ONCOLOGY ARABIA, BE PHARMACEUTICALS INC, FRESENIUS KABI USA LLC, EVERSANA — together control 63.6% of total enoxaparin import value from India.

Suresh Sormare

Enoxaparin

India Pharmaceutical Trade Intelligence

$209.4M223 Suppliers118 CountriesHS 30049099

ExportsIndia → UNITED STATES49.0%India → SAUDI ARABIA22.0%

ImportsFRANCE → India$2.7B CHINA → India$3.2M

#1 Supplier: GLAND PHARMA #1 Buyer: FRESENIUS KABI

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $102.7M through 744 shipments. This represents a market share of 49.0% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• FRESENIUS KABI USA, LLC - $48.6M (47.3% of country's total business)

• BE PHARMACEUTICALS INC - $20.9M (20.3% of country's total business)

• FRESENIUS KABI USA LLC - $12.0M (11.7% of country's total business)

• EVERSANA - $7.2M (7.0% of country's total business)

• FRESENIUS KABI USA LLC, - $4.8M (4.7% of country's total business)

• Rest of United States's importers - $9.2M (8.9% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $138.0K, indicating premium pricing strategy compared to the market average of $63.3K.

United States is a key market for Enoxaparin imports, representing 49.0% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Enoxaparin buyer market intelligence

1Buyer Segment Analysis

The 505 buyers of Enoxaparin imported from India can be categorized into several segments:

1. Distributors: Entities like EVERSANA and BE PHARMACEUTICALS INC in the United States fall into this category. They purchase Enoxaparin in bulk and distribute it to various healthcare providers, pharmacies, and hospitals. Their buying behavior typically involves large-volume orders to ensure a steady supply chain and meet the demands of their clients.

2. Hospital Groups: While specific hospital groups are not listed among the top 10 buyers, such entities procure Enoxaparin directly to administer to patients within their facilities. Their purchasing patterns are driven by patient needs and treatment protocols, often resulting in consistent, moderate-sized orders.

3. Government Procurement Agencies: The State Pharmaceuticals Corporation in Sri Lanka exemplifies this segment. Such agencies procure medications like Enoxaparin through national tenders to supply public healthcare institutions. Their buying behavior is characterized by large-scale, periodic purchases aligned with government healthcare programs and budgets.

4. Re-exporters: Entities that purchase Enoxaparin for the purpose of exporting to other countries. Their order patterns depend on the demand in their target markets and international trade agreements.

5. Contract Manufacturers: Companies that procure Enoxaparin as an active pharmaceutical ingredient (API) to produce finished dosage forms for other brands or markets. Their purchasing behavior is influenced by manufacturing schedules and contractual obligations.

Understanding these segments and their purchasing behaviors is crucial for suppliers aiming to tailor their strategies to meet the specific needs of each buyer type.

Country-Specific Import Regulations

TransData Nexus Enoxaparin buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries of Enoxaparin from India, the import regulations are as follows:

1. United States:

Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).

Import Registration Process: Importers must ensure that Enoxaparin is approved by the FDA. This involves submitting an Abbreviated New Drug Application (ANDA) or a New Drug Application (NDA) for review.

Estimated Timeline for Registration: The FDA review process can take approximately 10 to 12 months, depending on the completeness of the application and any additional information required.

Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS code 30049099 are generally duty-free in the United States.

2. Saudi Arabia:

Drug Regulatory Authority: Saudi Food and Drug Authority (SFDA).

Demand Drivers & Market Opportunity

TransData Nexus Enoxaparin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Enoxaparin in importing countries is driven by several key factors:

1. Disease Prevalence: Enoxaparin is primarily used for the prevention and treatment of thromboembolic disorders, which are prevalent globally. Conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE) contribute significantly to the demand for anticoagulant therapies.

2. Government Healthcare Programs: Many countries have implemented healthcare programs aimed at improving access to essential medicines. For instance, the World Health Organization (WHO) emphasizes the importance of essential medicines in healthcare systems, advocating for their availability and affordability. (iris.who.int)

3. Universal Health Coverage Expansion: The global push towards universal health coverage has led to increased procurement of essential medicines like Enoxaparin. Countries are striving to ensure that all individuals have access to necessary healthcare services, including medications.

4. WHO Essential Medicines List Procurement: Enoxaparin's inclusion in the WHO Essential Medicines List underscores its importance in treating thromboembolic conditions. This inclusion often influences national procurement decisions, leading to increased demand.

5. Tender-Based Purchasing: Many governments and healthcare institutions procure medicines through tender processes to ensure cost-effectiveness and quality. Enoxaparin is frequently included in such tenders, reflecting its critical role in healthcare.

With 505 buyers across 118 countries, the market for Enoxaparin presents substantial opportunities. Suppliers can leverage these demand drivers by aligning their strategies with national healthcare priorities and participating in tender processes to expand their market presence.

Common Questions — Enoxaparin Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest enoxaparin buyer importing from India?

Based on import volume and value, FRESENIUS KABI USA, LLC (UNITED STATES) leads with $48.6M in imports and a 23.2% market share — the highest of any single enoxaparin importer. BOSTON ONCOLOGY ARABIA (SAUDI ARABIA) and BE PHARMACEUTICALS INC (UNITED STATES) are the next largest buyers.

QHow many companies buy enoxaparin from India?

There are 505 active enoxaparin buyers importing from India, with a combined market of $209.4M across 3,309 shipments to 118 countries. The top 5 buyers hold 63.6% of total import value, while the remaining 500 buyers handle the other 36.4%.

QWhich countries import the most enoxaparin from India?

The top importing countries for enoxaparin from India are United States (49.0%), Saudi Arabia (22.0%), Sri Lanka (3.8%), Canada (2.5%), Dominican Republic (1.6%). These markets represent the largest demand centres for Indian pharmaceutical exports of enoxaparin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for enoxaparin from India?

The average import transaction value for enoxaparin from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Enoxaparin buyer market intelligence

1Buyer Segment Analysis

The 505 buyers of Enoxaparin imported from India can be categorized into several segments:

Understanding these segments and their purchasing behaviors is crucial for suppliers aiming to tailor their strategies to meet the specific needs of each buyer type.

Country-Specific Import Regulations

TransData Nexus Enoxaparin buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries of Enoxaparin from India, the import regulations are as follows:

1. United States:

Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).

Estimated Timeline for Registration: The FDA review process can take approximately 10 to 12 months, depending on the completeness of the application and any additional information required.

Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS code 30049099 are generally duty-free in the United States.

2. Saudi Arabia:

Drug Regulatory Authority: Saudi Food and Drug Authority (SFDA).

Demand Drivers & Market Opportunity

TransData Nexus Enoxaparin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Enoxaparin in importing countries is driven by several key factors:

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Enoxaparin

Enoxaparin

Who Buys Enoxaparin from India — 505 Importers Behind a $209.4M Market

Top Enoxaparin Importers — Ranked by Import Value

Top Enoxaparin Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Enoxaparin — and from which countries?

Enoxaparin — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Enoxaparin Buyers & Importers

QWho is the largest enoxaparin buyer importing from India?

QHow many companies buy enoxaparin from India?

QWhich countries import the most enoxaparin from India?

QWhat is the average import order value for enoxaparin from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2Saudi Arabia

3Sri Lanka

4Canada

5Dominican Republic

Analysis Methodology